Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the B-Raf inhibitor encorafenib, the EGFR inhibitors afatinib, erlotinib and gefitinib and the O-desmethyl metabolites of erlotinib and gefitinib in human plasma
Files
Publication date
2016-10-15
Authors
Sparidans, Rolf
Rosing, Hilde
Rood, Johannes J.M.
Schellens, Johannes
Beijnen, Jos
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Afatinib, Erlotinib, Gefitinib, Encorafenib, LC MS/MS, Plasma, Taverne
Citation
Sparidans, R W, Rosing, H, Rood, J J M, Schellens, J H M & Beijnen, J H 2016, 'Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the B-Raf inhibitor encorafenib, the EGFR inhibitors afatinib, erlotinib and gefitinib and the O-desmethyl metabolites of erlotinib and gefitinib in human plasma', Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 1033-1034, pp. 390-398. https://doi.org/10.1016/j.jchromb.2016.09.012